ALPMY (Astellas Pharma, Inc.) is held by 2 institutional investors as of Q4 2025. Largest holders: RHUMBLINE ADVISERS ($311,087), PNC FINANCIAL SERVICES GROUP, INC. ($744).
See how ALPMY's score breaks down across 4 SEC sources
No recent insider, activist, or congressional trades found for this stock
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer